Rick Hawkins is Chief Executive Officer and Chairman of Lumos Pharma. Previously, Mr. Hawkins founded Pharmaco and as Chairman, President and Chief Executive Officer, he managed the growth of that organization to over 700 employees.…

John McKew is President and Chief Scientific Officer of Lumos Pharma. Dr. McKew has twenty-seven years of experience developing novel therapeutics where he successfully advanced therapies through preclinical and into clinical development. Prior to Lumos…

Dr. Pisit "Duke" Pitukcheewanont is Lumos Pharma's Chief Medical Officer. A seasoned pediatric endocrinologist with over 25 years of combined clinical expertise and research contributions in the field, he currently serves as Adjunct Professor of…

Lori Lawley is Chief Financial Officer of Lumos Pharma. She brings over ten years of experience and accounting expertise in overseeing financial operations, including over five years of public company senior management experience in biotechnology.…

Brad Powers is the Chief Compliance Officer and General Counsel of Lumos Pharma. Prior to the merger with Lumos Pharma, he served as General Counsel at NewLink Genetics where he was directly responsible for all…

Aaron Schuchart is Chief Business Officer of Lumos Pharma.  Mr. Schuchart has over twenty years of experience in key leadership roles for both large multinationals and small biotech companies, including Amgen, Novartis Diagnostics/Grifols, and Coherus…

Alpa Parikh is Senior Vice President, CMC & Supply Management at Lumos Pharma. Ms. Parikh has over 30 years of experience in branded drug pharmaceutical development, from preclinical through commercialization of a new molecule. In…

Chris Bemben is Vice President, Business Development of Lumos Pharma. He brings 15 years of business and scientific experience developing novel therapeutics from discovery to late-stage clinical development. As a member of the senior management…

Michael Thorner is Vice President, Endocrine Sciences of Lumos Pharma. Dr. Thorner most recently was Chair of the Department of Medicine and preceding that was Chief of the Division of Endocrinology and Metabolism and Director…

Dr. Bruchey is an academically trained neuroscientist with over 25 years of expertise in development of biopharmaceuticals and devices in the areas of neurology, metabolic diseases, psychiatry, rare diseases, and endocrinology among others, with leadership…

Dr. Roy Smith is Scientific Advisor, Endocrine Science of Lumos Pharma. He has more than fifty years of academic and industrial research experience focused on drug discovery with over 300 peer-reviewed publications and issued patents.…

Dave Schrader is the Vice President, Quality and Compliance of Lumos Pharma.  He brings twenty years of experience holding various quality and compliance roles throughout his career in the pharmaceutical industry.  Prior to the merger…

Rick Hawkins is Chief Executive Officer and Chairman of Lumos Pharma. Previously, Mr. Hawkins founded Pharmaco and as Chairman, President and Chief Executive Officer, he managed the growth of that organization to over 700 employees.…

Thomas A. Raffin, M.D., has served as a member of the Board since 1999 and has been the Board’s Lead Independent Director since October 2010. Dr. Raffin has spent 30 years on the faculty at…

Kevin Lalande, MBA, is a Co-Founder and Managing Director of Santé Ventures, a healthcare and life science venture capital firm founded in 2006 which currently manages over $500 million across three funds with 30+ portfolio…

Chad A. Johnson, JD, has served as a member of NewLink Genetics’ Board (now Lumos Pharma) since March 2018. Mr. Johnson is currently Senior Counsel at BASF. From May 2017 to October 2022, Mr. Johnson…

Lota S. Zoth, CPA, has served as a member of NewLink Genetics’ Board (now Lumos Pharma) and Chair of our Audit Committee since November 2012. Ms. Zoth currently also serves on the Board of Directors…

Dr. McCracken has more than twenty-five years of experience in the pharmaceutical and biotechnology industry. Until his retirement in 2013, he had a successful career in the industry where he held top managerial positions in…

Dr. An van Es-Johansson, M.D. has served as a member of our Board since February 2021.  Dr. van Es-Johansson currently serves as a senior advisor for start up companies. Dr. van Es-Johansson was previously the…

Dr. Bach is a pediatric endocrinologist with 30 years of clinical research and pharmaceutical development experience, including extensive global experience building and leading clinical teams that have successfully launched innovative pharmaceutical products into global markets.…

Dr. Clayton has been a Professor of Child Health and Paediatric Endocrinology at the University of Manchester since 2001. He has authored 200 publications on the clinical and basic science aspects of pediatric endocrinology and…

Dr. Horikawa, a pediatric endocrinologist, is the Director of the Endocrinology and Metabolism Division of the Japanese National Center for Child Health and Development (NCCHD) and has been with the NCCHD since 2002. She is…

Dr. Rosenfeld serves as Professor and Chair (emeritus) of Pediatrics, Oregon Health & Science University in addition to his role as President of STAT5, LLC.  The author of over 600 publications and eight-edited books, Rosenfeld…

Professor George Werther, a pediatric endocrinologist, is Director of the Centre for Hormone Research at Murdoch Children’s Research Institute and Director of Endocrinology at the Royal Children's Hospital (RCH) in Melbourne. Werther has been involved…